Antonio Cuevas-Navarro
9PUBLICATIONS
92CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jul 11, 2025
RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung Adenocarcinoma.Alessandro M Mozzarelli, Antonio Cuevas-Navarro, Emily G Shuldiner
|Oct 30, 2024
Pharmacological restoration of GTP hydrolysis by mutant RAS.Antonio Cuevas-Navarro, Yasin Pourfarjam, Feng Hu
|Apr 08, 2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.Matthew Holderfield, Bianca J Lee, Jingjing Jiang
|Aug 17, 2023
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS.Christopher J Schulze, Kyle J Seamon, Yulei Zhao
|Jul 14, 2023
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy.Antonio Cuevas-Navarro, Morgan Wagner, Richard Van
|May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth.Dongsung Kim, Lorenz Herdeis, Dorothea Rudolph
Pageof 2
Frequent Collaborators
5 joint publications
Pau Castel
4 joint publications
Frank McCormick
4 joint publications
Piro Lito
3 joint publications
Dhirendra K Simanshu
3 joint publications
Anatoly Urisman
2 joint publications
Simon Messing
2 joint publications
Feng Hu
2 joint publications
Jacqueline A M Smith
2 joint publications
Yulei Zhao
2 joint publications
Dongsung Kim
